115 related articles for article (PubMed ID: 38767086)
1. Hypofractionated Radiotherapy-Related Lymphopenia Is Associated With Worse Survival in Unresectable Intrahepatic Cholangiocarcinoma.
Lee G; Kim DW; Smart AC; Horick NK; Eyler CE; Roberts HJ; Pathak P; Goyal L; Franses J; Heather JM; Hwang WL; Grassberger C; Klempner SJ; Drapek LC; Allen JN; Blaszkowsky LS; Parikh AR; Ryan DP; Clark JW; Hong TS; Wo JY
Am J Clin Oncol; 2024 May; ():. PubMed ID: 38767086
[TBL] [Abstract][Full Text] [Related]
2. Radiation-Associated Lymphopenia and Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Radiotherapy.
De B; Ng SP; Liu AY; Avila S; Tao R; Holliday EB; Brownlee Z; Kaseb A; Lee S; Raghav K; Vauthey JN; Minsky BD; Herman JM; Das P; Smith GL; Taniguchi CM; Krishnan S; Crane CH; Grassberger C; Hong TS; Lin SH; Koong AC; Mohan R; Koay EJ
J Hepatocell Carcinoma; 2021; 8():57-69. PubMed ID: 33688489
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of absolute lymphocyte count in patients with advanced esophageal cancer treated with immunotherapy: a retrospective analysis.
Zhao Q; Bi Y; Xue J; Liu Y; Zhu J; Qin S
Ann Transl Med; 2022 Jul; 10(13):744. PubMed ID: 35957729
[TBL] [Abstract][Full Text] [Related]
4. Does Unintentional Splenic Radiation Predict Outcomes After Pancreatic Cancer Radiation Therapy?
Chadha AS; Liu G; Chen HC; Das P; Minsky BD; Mahmood U; Delclos ME; Suh Y; Sawakuchi GO; Beddar S; Katz MH; Fleming JB; Javle MM; Varadhachary GR; Wolff RA; Crane CH; Wang X; Thames H; Krishnan S
Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):323-332. PubMed ID: 28068240
[TBL] [Abstract][Full Text] [Related]
5. A machine learning model for grade 4 lymphopenia prediction during pelvic radiotherapy in patients with cervical cancer.
Xu Z; Yang L; Yu H; Guo L
Front Oncol; 2022; 12():905222. PubMed ID: 36185193
[TBL] [Abstract][Full Text] [Related]
6. Interaction between lymphopenia, radiotherapy technique, dosimetry, and survival outcomes in lung cancer patients receiving combined immunotherapy and radiotherapy.
Chen D; Patel RR; Verma V; Ramapriyan R; Barsoumian HB; Cortez MA; Welsh JW
Radiother Oncol; 2020 Sep; 150():114-120. PubMed ID: 32525003
[TBL] [Abstract][Full Text] [Related]
7. Hypofractionated Radiation Therapy for Unresectable/Locally Recurrent Intrahepatic Cholangiocarcinoma.
Smart AC; Goyal L; Horick N; Petkovska N; Zhu AX; Ferrone CR; Tanabe KK; Allen JN; Drapek LC; Qadan M; Murphy JE; Eyler CE; Ryan DP; Hong TS; Wo JY
Ann Surg Oncol; 2020 Apr; 27(4):1122-1129. PubMed ID: 31873931
[TBL] [Abstract][Full Text] [Related]
8. Splenic irradiation contributes to grade ≥ 3 lymphopenia after adjuvant chemoradiation for stomach cancer.
Lee SF; Yip PL; Wong A; Ng F; Koh V; Wong LC; Luk H; Ng CK; Lee FAS; Mamon HJ
Clin Transl Radiat Oncol; 2022 Sep; 36():83-90. PubMed ID: 35909437
[TBL] [Abstract][Full Text] [Related]
9. Low Lymphocyte Count Is Associated With Radiotherapy Parameters and Affects the Outcomes of Esophageal Squamous Cell Carcinoma Patients.
Wang X; Zhao Z; Wang P; Geng X; Zhu L; Li M
Front Oncol; 2020; 10():997. PubMed ID: 32656085
[No Abstract] [Full Text] [Related]
10. Radiation-induced lymphopenia correlates with survival in nasopharyngeal carcinoma: impact of treatment modality and the baseline lymphocyte count.
Xie X; Gong S; Jin H; Yang P; Xu T; Cai Y; Guo C; Zhang R; Lou F; Yang W; Wang H
Radiat Oncol; 2020 Mar; 15(1):65. PubMed ID: 32169088
[TBL] [Abstract][Full Text] [Related]
11. Effect of Radiation Treatment Volume Reduction on Lymphopenia in Patients Receiving Chemoradiotherapy for Glioblastoma.
Rudra S; Hui C; Rao YJ; Samson P; Lin AJ; Chang X; Tsien C; Fergus S; Mullen D; Yang D; Thotala D; Hallahan D; Campian JL; Huang J
Int J Radiat Oncol Biol Phys; 2018 May; 101(1):217-225. PubMed ID: 29502931
[TBL] [Abstract][Full Text] [Related]
12. The Prognostic Value of Treatment-Related Lymphopenia in Nasopharyngeal Carcinoma Patients.
Liu LT; Chen QY; Tang LQ; Guo SS; Guo L; Mo HY; Chen MY; Zhao C; Guo X; Qian CN; Zeng MS; Bei JX; Tan J; Chen S; Hong MH; Shao JY; Sun Y; Ma J; Mai HQ
Cancer Res Treat; 2018 Jan; 50(1):19-29. PubMed ID: 28392551
[TBL] [Abstract][Full Text] [Related]
13. Proton and Carbon Ion Radiation Therapy Decreased Severe Lymphopenia by Reducing Thoracic Vertebra and Aortic Doses in Non-Small Cell Lung Cancer Versus Intensity Modulated Radiation Therapy.
Li Y; Fan X; Yu Q; Zhai H; Mo M; Sun J; Mi J; Lu R; Mao J; Chen J; Ma N; Yang W; Zhu J; Jiang G; Wu K
Int J Radiat Oncol Biol Phys; 2023 Jul; 116(3):579-589. PubMed ID: 36586495
[TBL] [Abstract][Full Text] [Related]
14. Treatment-duration is related to changes in peripheral lymphocyte counts during definitive radiotherapy for unresectable stage III NSCLC.
Zhao Q; Chen G; Ye L; Shi S; Du S; Zeng Z; He J
Radiat Oncol; 2019 May; 14(1):86. PubMed ID: 31133034
[TBL] [Abstract][Full Text] [Related]
15. The Impact of Radiation Therapy on Lymphocyte Count and Survival in Metastatic Cancer Patients Receiving PD-1 Immune Checkpoint Inhibitors.
Pike LRG; Bang A; Mahal BA; Taylor A; Krishnan M; Spektor A; Cagney DN; Aizer AA; Alexander BM; Rahma O; Balboni T; Ott PA; Hodi FS; Schoenfeld JD
Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):142-151. PubMed ID: 30227198
[TBL] [Abstract][Full Text] [Related]
16. Lymphopenia association with accelerated hyperfractionation and its effects on limited-stage small cell lung cancer patients' clinical outcomes.
Wang X; Lu J; Teng F; Yu J
Ann Transl Med; 2019 Aug; 7(16):385. PubMed ID: 31555699
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy-related lymphopenia in patients with advanced non-small cell lung cancer receiving palliative radiotherapy.
Abravan A; Eide HA; Helland Å; Malinen E
Clin Transl Radiat Oncol; 2020 May; 22():15-21. PubMed ID: 32181373
[TBL] [Abstract][Full Text] [Related]
18. Radiation-related lymphopenia as a new prognostic factor in limited-stage small cell lung cancer.
Cho O; Oh YT; Chun M; Noh OK; Lee HW
Tumour Biol; 2016 Jan; 37(1):971-8. PubMed ID: 26264618
[TBL] [Abstract][Full Text] [Related]
19. Early onset of severe lymphopenia during definitive radiotherapy correlates with mean body dose and predicts poor survival in cervical cancer.
Yang L; Xu Z; Ma L; Liu Q; Chang ATY; Wang Q; Zha J; Zhang J; Jiang X; Zhang J; Kong FS; Guo L
Cancer Biomark; 2022; 34(1):149-159. PubMed ID: 35094986
[TBL] [Abstract][Full Text] [Related]
20. Risk of on-treatment lymphopenia is associated with treatment outcome and efficacy of consolidation immunotherapy in patients with non-small cell lung cancer treated with concurrent chemoradiotherapy.
Yang G; Yoon HI; Lee J; Kim J; Kim H; Cho J; Lee CG; Chang JS; Cho Y; Kim JS; Kim KH
Radiother Oncol; 2023 Dec; 189():109934. PubMed ID: 37783291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
